Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
44.94
-1.06 (-2.30%)
Mar 3, 2026, 9:56 AM EST - Market open
KNSA Market Cap
KNSA has a market cap or net worth of $3.44 billion as of March 3, 2026. Its market cap has increased by 147.08% in one year.
Market Cap
3.44B
Enterprise Value
3.12B
1-Year Change
147.08%
Ranking
Category
Stock Price
$44.94
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $3.44B, an increase of 264.69%. That is a compound annual growth rate of 18.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.41B | 8.91% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 5.02B |
| Lantheus Holdings | 4.97B |
| Amneal Pharmaceuticals | 4.34B |
| Hims & Hers Health | 3.31B |
| Prestige Consumer Healthcare | 3.28B |
| Supernus Pharmaceuticals | 3.14B |
| HUTCHMED (China) | 2.49B |
| Phibro Animal Health | 2.21B |